| Released | Contributor | Author | Title | Pages | Price |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for CRXL | 13 |
$25 |
| 29-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for MEDICAL SUPPLIES | 18 |
$49 |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Crucell NV has a current Overall Rating of C (Neutral). | 7 |
$25 |
| 28-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Biotechnology Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 18 new Laggards. | 58 |
$20 |
| 28-Nov-2009 | TheStreet.com Ratings |
N/A
| TheStreet.com Ratings Stock Report For: CRUCELL NV | 5 |
$25 |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | C QUENTIAL INC CL A (CRXL=US) 2-weeks forecast | 1 |
$10 |
| 27-Nov-2009 | Pechala's Reports | Frantisek Pechala | C QUENTIAL INC CL A (CRXL=US) 12-months forecast | 1 |
$15 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: BMRN , CRXL , NPSP , PGNX , RIGL , ZGEN -- DRUGS | 3 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: CRUCELL -- CRXL | 1 |
$4 |
| 23-Nov-2009 | Zacks Investment Research Inc. |
N/A
| CRUCELL-ADR (CRXL) Zacks Company Snapshot | 1 |
$10 |
0.48% Nasdaq 
Research Reports
